Cargando…

Down-Regulation of Ca(2+)-Activated K(+) Channel K(Ca)1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists

Vitamin D (VD) reduces the risk of breast cancer and improves disease prognoses. Potential VD analogs are being developed as therapeutic agents for breast cancer treatments. The large-conductance Ca(2+)-activated K(+) channel K(Ca)1.1 regulates intracellular Ca(2+) signaling pathways and is associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khatun, Anowara, Fujimoto, Mayu, Kito, Hiroaki, Niwa, Satomi, Suzuki, Takayoshi, Ohya, Susumu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187883/ https://www.ncbi.nlm.nih.gov/pubmed/27973439 http://dx.doi.org/10.3390/ijms17122083

Ejemplares similares

Transcriptional Repression and Protein Degradation of the Ca(2+)-Activated K(+) Channel K(Ca)1.1 by Androgen Receptor Inhibition in Human Breast Cancer Cells
por: Khatun, Anowara, et al.
Publicado: (2018)

Downregulation of the Ca(2+)‐activated K(+) channel K(C) (a)3.1 by histone deacetylase inhibition in human breast cancer cells
por: Ohya, Susumu, et al.
Publicado: (2016)

Ca(2+)‐activated K(+) channel K(Ca)1.1 as a therapeutic target to overcome chemoresistance in three‐dimensional sarcoma spheroid models
por: Ohya, Susumu, et al.
Publicado: (2021)

Histone Deacetylases Enhance Ca(2+)-Activated K(+) Channel K(Ca)3.1 Expression in Murine Inflammatory CD4(+) T Cells
por: Matsui, Miki, et al.
Publicado: (2018)

Role of K(+) and Ca(2+)-Permeable Channels in Osteoblast Functions
por: Kito, Hiroaki, et al.
Publicado: (2021)

Downregulation of IL-8 and IL-10 by the Activation of Ca(2+)-Activated K(+) Channel K(Ca)3.1 in THP-1-Derived M(2) Macrophages
por: Ohya, Susumu, et al.
Publicado: (2022)

Down-Regulation of CYP3A4 by the K(Ca)1.1 Inhibition Is Responsible for Overcoming Resistance to Doxorubicin in Cancer Spheroid Models
por: Ohya, Susumu, et al.
Publicado: (2023)

Effects of hirsuteine on MDA-MB-453 breast cancer cell proliferation
por: Meng, Jie, et al.
Publicado: (2022)

K(Ca)1.1 K(+) Channel Inhibition Overcomes Resistance to Antiandrogens and Doxorubicin in a Human Prostate Cancer LNCaP Spheroid Model
por: Ohya, Susumu, et al.
Publicado: (2021)

Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line
por: Singh, Gobind, et al.
Publicado: (2011)

Plasmid DNA delivery into MDA-MB-453 cells mediated by recombinant Her-NLS fusion protein
por: Jeyarajan, Sivakumar, et al.
Publicado: (2010)

Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells
por: Choi, Eun Jeong, et al.
Publicado: (2008)

Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells
por: Choi, Eun Jeong, et al.
Publicado: (2009)

Multifunctional Cu(2−x)Te Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453
por: Poulose, Aby Cheruvathoor, et al.
Publicado: (2016)

Investigation of Transcript Variant 6 of TPD52L2 as a Prognostic and Predictive Biomarker in Basal-Like MDA-MB-231 and MDA-MB-453 Cell Lines for Breast Cancer
por: Zhang, Xin, et al.
Publicado: (2022)

5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells
por: YAO, YONGSHAN, et al.
Publicado: (2014)

CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM)
por: Wege, Anja Kathrin, et al.
Publicado: (2021)

Possible Contribution of Inflammation-Associated Hypoxia to Increased K(2P)5.1 K(+) Channel Expression in CD4(+) T Cells of the Mouse Model for Inflammatory Bowel Disease
por: Endo, Kyoko, et al.
Publicado: (2019)

Regulation of the FOXO3a/Bim signaling pathway by 5,7-dihydroxy-8-nitrochrysin in MDA-MB-453 breast cancer cells
por: ZHAO, XIAO-CHUN, et al.
Publicado: (2013)

PGRMC1 Inhibits Progesterone-Evoked Proliferation and Ca(2+) Entry Via STIM2 in MDA-MB-231 Cells
por: Cantonero, Carlos, et al.
Publicado: (2020)

Transcriptional repression of human epidermal growth factor receptor 2 by ClC‐3 Cl(−)/H(+) transporter inhibition in human breast cancer cells
por: Fujimoto, Mayu, et al.
Publicado: (2018)

Cancer-Associated Intermediate Conductance Ca(2+)-Activated K(+) Channel K(Ca)3.1
por: Mohr, Corinna J., et al.
Publicado: (2019)

K(Ca)2 and K(Ca)3.1 Channels in the Airways: A New Therapeutic Target
por: Orfali, Razan, et al.
Publicado: (2023)

Activation of BK(Ca) Channels in Zoledronic Acid-Induced Apoptosis of MDA-MB-231 Breast Cancer Cells
por: Ma, Yu-Guang, et al.
Publicado: (2012)

G-Protein Inwardly Rectifying Potassium Channel 1 (GIRK1) Knockdown Decreases Beta-Adrenergic, MAP Kinase and Akt Signaling in the MDA-MB-453 Breast Cancer Cell Line
por: Hance, Michael W., et al.
Publicado: (2008)

Study of the Role of siRNA Mediated Promoter Methylation in DNMT3B Knockdown and Alteration of Promoter Methylation of CDH1, GSTP1 Genes in MDA-MB -453 Cell Line
por: Naghitorabi, Mojgan, et al.
Publicado: (2017)

Non-Stimulated, Agonist-Stimulated and Store-Operated Ca(2+) Influx in MDA-MB-468 Breast Cancer Cells and the Effect of EGF-Induced EMT on Calcium Entry
por: Davis, Felicity M., et al.
Publicado: (2012)

Berberine Inhibits MDA-MB-231 Cells as an Agonist of G Protein-Coupled Estrogen Receptor 1
por: Qi, Miaomiao, et al.
Publicado: (2021)

K(Ca)2 and K(Ca)3 Channels in Learning and Memory Processes, and Neurodegeneration
por: Kuiper, Els F. E., et al.
Publicado: (2012)

The Cytotoxic Effect of Magainin II on the MDA-MB-231 and M14K Tumour Cell Lines
por: Anghel, Radu, et al.
Publicado: (2013)

Internalization and Transportation of Endothelial Cell Surface K(Ca)2.3 and K(Ca)3.1 in Normal Pregnancy and Preeclampsia
por: Choi, Shinkyu, et al.
Publicado: (2019)

Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7
por: Terasaki, Azusa, et al.
Publicado: (2020)

Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in K(Ca)2.3 and K(Ca)3.1 Channels
por: Wandall-Frostholm, Christine, et al.
Publicado: (2014)

Differential contributions of Ca(2+)‐activated K(+) channels and Na(+)/K(+)‐ATPases to the generation of the slow afterhyperpolarization in CA1 pyramidal cells
por: Tiwari, Manindra Nath, et al.
Publicado: (2018)

Functional K(Ca)3.1 K(+) channels are required for human fibrocyte migration
por: Cruse, Glenn, et al.
Publicado: (2011)

Cytotoxicity and Synergistic Effect of Biogenically Synthesized Ternary Therapeutic Nano Conjugates Comprising Plant Active Principle, Silver and Anticancer Drug on MDA-MB-453 Breast Cancer Cell Line
por: Karuppaiah, Arjunan, et al.
Publicado: (2020)

K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
por: Klumpp, Lukas, et al.
Publicado: (2018)

PRIMA-1(MET) Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023)

Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K(+) Channel K(V)1.2 and Small- and Intermediate-Conductance Ca(2+)-Activated K(+) Channels K(Ca)2.2 and K(Ca)3.1
por: Naseem, Muhammad Umair, et al.
Publicado: (2023)

Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of K(Ca)2.x and K(Ca)3.1 Channels
por: Kloza, Monika, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b4l5mv94q2s8oea6324578mhd0